메뉴 건너뛰기




Volumn 50, Issue , 1999, Pages 1-15

Cyclosporine treatment of glomerular diseases

Author keywords

Cyclosporine; Glomerular disease treatment; Nephrotic syndrome; Toxicity

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; STEROID;

EID: 0032977927     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.1     Document Type: Review
Times cited : (34)

References (72)
  • 2
    • 0029974552 scopus 로고    scopus 로고
    • Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy
    • 2. Ambalavanan S, Fauvel JP, Sibley RK, Myers BD. 1996. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy. J. Am. Soc. Nephrol. 7:290-98
    • (1996) J. Am. Soc. Nephrol. , vol.7 , pp. 290-298
    • Ambalavanan, S.1    Fauvel, J.P.2    Sibley, R.K.3    Myers, B.D.4
  • 4
    • 0027289728 scopus 로고
    • Mechanisms of proteinuria in noninflammatory glomerular diseases
    • 4. Savin VJ. 1993. Mechanisms of proteinuria in noninflammatory glomerular diseases. Am. J. Kidney Dis. 21:347-62
    • (1993) Am. J. Kidney Dis. , vol.21 , pp. 347-362
    • Savin, V.J.1
  • 5
    • 0023850641 scopus 로고
    • Cyclosporine A induced remission of relapsing nephrotic syndrome in children
    • 5. Tejani AT, Butt K, Trachtman H, et al. 1988. Cyclosporine A induced remission of relapsing nephrotic syndrome in children. Kidney Int. 33: 729-34
    • (1988) Kidney Int. , vol.33 , pp. 729-734
    • Tejani, A.T.1    Butt, K.2    Trachtman, H.3
  • 6
    • 0025744933 scopus 로고
    • A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children
    • 6. Tejani A, Suthanthiran M, Pomrantz A. 1991. A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. Nephron 59:96-99
    • (1991) Nephron , vol.59 , pp. 96-99
    • Tejani, A.1    Suthanthiran, M.2    Pomrantz, A.3
  • 7
    • 0001196817 scopus 로고
    • Results of a 6 month randomized controlled trial of cyclosporine (T) vs placebo (c) in adults with steroid resistant idiopathic focal segmental glomerulosclerosis (SR-FSGS)
    • Abstr.
    • 7. Cattran D, Greenwood C, Bernstein K, et al. 1995. Results of a 6 month randomized controlled trial of cyclosporine (T) vs placebo (c) in adults with steroid resistant idiopathic focal segmental glomerulosclerosis (SR-FSGS). J. Am. Soc. Nephrol. 6:415 (Abstr.)
    • (1995) J. Am. Soc. Nephrol. , vol.6 , pp. 415
    • Cattran, D.1    Greenwood, C.2    Bernstein, K.3
  • 8
    • 0022922196 scopus 로고
    • Cyclosporine A in nephrotic syndrome of childhood-a 14 month experience
    • 8. Capodicasa G, De Santo NG, Nuzzi F. 1986. Cyclosporine A in nephrotic syndrome of childhood-a 14 month experience. Int. J. Pediatr. Nephrol. 7:69-72
    • (1986) Int. J. Pediatr. Nephrol. , vol.7 , pp. 69-72
    • Capodicasa, G.1    De Santo, N.G.2    Nuzzi, F.3
  • 9
    • 0023690632 scopus 로고
    • Cyclosporine therapy for steroid-resistant nephrotic syndrome
    • 9. Garin EH, Orak JK, Hiott KL. 1988. Cyclosporine therapy for steroid-resistant nephrotic syndrome. Am. J. Dis. Child. 142: 985-88
    • (1988) Am. J. Dis. Child. , vol.142 , pp. 985-988
    • Garin, E.H.1    Orak, J.K.2    Hiott, K.L.3
  • 10
    • 0027162801 scopus 로고
    • A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome
    • 10. Ponticelli C, Rizzoni G, Edefonti A, et al. 1993. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 43:1377-84
    • (1993) Kidney Int. , vol.43 , pp. 1377-1384
    • Ponticelli, C.1    Rizzoni, G.2    Edefonti, A.3
  • 11
    • 0028034878 scopus 로고
    • Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone
    • French Society of Pediatric Nephrology
    • 10a. Niaudet P. 1994. Treatment of childhood steroid-resistant idiopathic nephrosis with a combination of cyclosporine and prednisone. French Society of Pediatric Nephrology. J. Pediatr. 125:981-86
    • (1994) J. Pediatr. , vol.125 , pp. 981-986
    • Niaudet, P.1
  • 12
    • 0026503844 scopus 로고
    • Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: A multicentre randomized controlled trial
    • 11. Niaudet P. 1992. Comparison of cyclosporin and chlorambucil in the treatment of steroid-dependent idiopathic nephrotic syndrome: a multicentre randomized controlled trial. Pediatr. Nephrol. 6:1-3
    • (1992) Pediatr. Nephrol. , vol.6 , pp. 1-3
    • Niaudet, P.1
  • 13
    • 0023131320 scopus 로고
    • Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporine
    • 12. DeSanto NG, Capodicasa G, Giordano C. 1989. Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporine. Am. J. Nephrol. 7: 74-76
    • (1989) Am. J. Nephrol. , vol.7 , pp. 74-76
    • DeSanto, N.G.1    Capodicasa, G.2    Giordano, C.3
  • 14
    • 0028941295 scopus 로고
    • A controlled trial of cyclosporin in patients with progressive membranous nephropathy
    • 13. Cattran DC, Greenwood C, Ritchie S, et al. 1995. A controlled trial of cyclosporin in patients with progressive membranous nephropathy. Kidney Int. 47:1130-35
    • (1995) Kidney Int. , vol.47 , pp. 1130-1135
    • Cattran, D.C.1    Greenwood, C.2    Ritchie, S.3
  • 15
    • 85031581890 scopus 로고    scopus 로고
    • Randomized controlled trial of cyclosporine (D) vs placebo (P) in steroid resistant, nephrotic patients (NS) with membranous nephropathy (SR-MGN)
    • (Abstr.) In press
    • 13a. Cattran DC, Pohl M, Maxwell D, et al, for North American Nephrotic Syndrome Study Group. 1998. Randomized controlled trial of cyclosporine (D) vs placebo (P) in steroid resistant, nephrotic patients (NS) with membranous nephropathy (SR-MGN). J. Am. Soc. Nephrol. (Abstr.) In press
    • (1998) J. Am. Soc. Nephrol.
    • Cattran, D.C.1    Pohl, M.2    Maxwell, D.3
  • 16
    • 0023909687 scopus 로고
    • The effect of cyclosporine in idiopathic nephrotic syndrome resistant to immunosuppressive therapy
    • 14. Erbay B, Karatan O, Duman N, Ertug AE. 1988. The effect of cyclosporine in idiopathic nephrotic syndrome resistant to immunosuppressive therapy. Transplant Proc. 20:292 (Suppl. 4)
    • (1988) Transplant Proc. , vol.20 , Issue.SUPPL. 4 , pp. 292
    • Erbay, B.1    Karatan, O.2    Duman, N.3    Ertug, A.E.4
  • 17
    • 0027516549 scopus 로고    scopus 로고
    • Long term cyclosporin A therapy for severe idiopathic membranous nephropathy
    • 15. Rostoker G, Maadi AB, Sandreux T. 1997. Long term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 63:335-41
    • (1997) Nephron , vol.63 , pp. 335-341
    • Rostoker, G.1    Maadi, A.B.2    Sandreux, T.3
  • 18
    • 0027731266 scopus 로고
    • Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: A multicenter randomized controlled trial
    • 16. Ponticelli C, Edefonti A, Ghio L, et al. 1993. Cyclosporin versus cyclophosphamide for patients with steroid-dependent and frequently relapsing idiopathic nephrotic syndrome: a multicenter randomized controlled trial. Nephrol. Dial. Transplant. 8:1326-32
    • (1993) Nephrol. Dial. Transplant. , vol.8 , pp. 1326-1332
    • Ponticelli, C.1    Edefonti, A.2    Ghio, L.3
  • 19
    • 0026903242 scopus 로고
    • Severe hypercholesterolemia inhibits cyclosporine A efficacy in a dose-dependent manner in children with nephrotic syndrome
    • 17. Ingulli E, Tejani A. 1992. Severe hypercholesterolemia inhibits cyclosporine A efficacy in a dose-dependent manner in children with nephrotic syndrome. J. Am. Soc. Nephrol. 3:254-59
    • (1992) J. Am. Soc. Nephrol. , vol.3 , pp. 254-259
    • Ingulli, E.1    Tejani, A.2
  • 20
    • 0021345894 scopus 로고
    • Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy
    • 18. Ponticelli C, Zuchelli P, Imbasciati E, et al. 1984. Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N. Engl. J. Med. 310:946-50
    • (1984) N. Engl. J. Med. , vol.310 , pp. 946-950
    • Ponticelli, C.1    Zuchelli, P.2    Imbasciati, E.3
  • 21
    • 0028212949 scopus 로고
    • Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome
    • Collaborative Group of the Societé de Nephrologie
    • 19. Meyrier A, Noel L, Auriche P, Callard P. 1994. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Collaborative Group of the Societé de Nephrologie. Kidney Int. 45:1446-56
    • (1994) Kidney Int. , vol.45 , pp. 1446-1456
    • Meyrier, A.1    Noel, L.2    Auriche, P.3    Callard, P.4
  • 22
    • 0027991761 scopus 로고    scopus 로고
    • Treatment of the nephrotic syndrome associated with primary glomerulonephritis
    • 20. Ponticelli C, Passerini P. 1997. Treatment of the nephrotic syndrome associated with primary glomerulonephritis. Kidney Int. 46:595-604
    • (1997) Kidney Int. , vol.46 , pp. 595-604
    • Ponticelli, C.1    Passerini, P.2
  • 23
    • 0028358714 scopus 로고
    • Primary focal segmental glomerulosclerosis: Clinical course and response to therapy
    • 21. Korbet SM, Schwartz MM, Lewis EJ. 1994. Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am. J. Kidney Dis. 23:773-83
    • (1994) Am. J. Kidney Dis. , vol.23 , pp. 773-783
    • Korbet, S.M.1    Schwartz, M.M.2    Lewis, E.J.3
  • 24
    • 0013569320 scopus 로고    scopus 로고
    • note
    • 22. Deleted in proof
  • 25
    • 0001196817 scopus 로고
    • Follow up results from a randomized controlled trial (RCT) of cyclosporine (T) vs placebo (C) in adults with steroid resistant idiopathic focal segmental glomerulosclerosis (SR-FSGS)
    • Abstr.
    • 23. Cattran D, Greenwood C, Hebert L, et al. 1995. Follow up results from a randomized controlled trial (RCT) of cyclosporine (T) vs placebo (C) in adults with steroid resistant idiopathic focal segmental glomerulosclerosis (SR-FSGS). J. Am. Soc. Nephrol. 6:414 (Abstr.)
    • (1995) J. Am. Soc. Nephrol. , vol.6 , pp. 414
    • Cattran, D.1    Greenwood, C.2    Hebert, L.3
  • 26
    • 0025894089 scopus 로고
    • Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: Minimal-change disease and focal-segmental glomerulosclerosis
    • 24. Meyrier A, Condamin MC, Broneer D, Collaborative Group of the French Society of Nephrology. 1991. Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Clin. Nephrol. 35:37-42 (Suppl. 1)
    • (1991) Clin. Nephrol. , vol.35 , Issue.SUPPL. 1 , pp. 37-42
    • Meyrier, A.1    Condamin, M.C.2    Broneer, D.3
  • 27
    • 0025844854 scopus 로고
    • Treatment of idiopathic nephrotic syndrome with cyclosporin A in children
    • 25. Niaudet P, Broyer M, Habib R. 1991. Treatment of idiopathic nephrotic syndrome with cyclosporin A in children. Clin. Nephrol. 35:531-36 (Suppl. 1)
    • (1991) Clin. Nephrol. , vol.35 , Issue.SUPPL. 1 , pp. 531-536
    • Niaudet, P.1    Broyer, M.2    Habib, R.3
  • 28
    • 0028785260 scopus 로고
    • A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
    • 26. Ponticelli C, Zucchelli P. 1995. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int. 48:1600-4
    • (1995) Kidney Int. , vol.48 , pp. 1600-1604
    • Ponticelli, C.1    Zucchelli, P.2
  • 29
    • 0027314667 scopus 로고
    • Prognosis of untreated patients with idiopathic membranous nephropathy
    • 27. Schiepatti MD, Mosconi L, Perna A, et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N. Engl. J. Med. 1993;329:85-89
    • (1993) N. Engl. J. Med. , vol.329 , pp. 85-89
    • Schiepatti, M.D.1    Mosconi, L.2    Perna, A.3
  • 30
    • 0029009350 scopus 로고
    • A review of therapeutic studies of idiopathic membranous glomerulopathy
    • 28. Hogan SL, Muller KE, Jennette JC, Falk RJ. 1995. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am. J. Kidney Dis. 25:862-75
    • (1995) Am. J. Kidney Dis. , vol.25 , pp. 862-875
    • Hogan, S.L.1    Muller, K.E.2    Jennette, J.C.3    Falk, R.J.4
  • 31
    • 0028998429 scopus 로고
    • Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials
    • 29. Imperiale TF, Goldfarb S, Berns JS. 1995. Are cytotoxic agents beneficial in idiopathic membranous nephropathy? A meta-analysis of the controlled trials. J. Am. Soc. Nephrol. 5:1543-45
    • (1995) J. Am. Soc. Nephrol. , vol.5 , pp. 1543-1545
    • Imperiale, T.F.1    Goldfarb, S.2    Berns, J.S.3
  • 32
    • 0026468259 scopus 로고
    • Short-term responsiveness of membranous glomerulopathy to cyclosporine
    • 30. Guasch A, Suranyi M, Newton L, et al. 1992. Short-term responsiveness of membranous glomerulopathy to cyclosporine. Am. J. Kidney Dis. 20:472-81
    • (1992) Am. J. Kidney Dis. , vol.20 , pp. 472-481
    • Guasch, A.1    Suranyi, M.2    Newton, L.3
  • 33
    • 0023584098 scopus 로고
    • The commonest glomerulonephritis in the world: IgA nephropathy
    • 31. D'Amico G. 1987. The commonest glomerulonephritis in the world: IgA nephropathy. Q. J. Med. 64:709-27
    • (1987) Q. J. Med. , vol.64 , pp. 709-727
    • D'Amico, G.1
  • 34
    • 0025897388 scopus 로고
    • Long term follow up of renal function in IgA nephropathy
    • 32. Berg UB. 1991. Long term follow up of renal function in IgA nephropathy. Arch. Dis. Child 66:588-92
    • (1991) Arch. Dis. Child , vol.66 , pp. 588-592
    • Berg, U.B.1
  • 35
    • 0027428301 scopus 로고
    • Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy
    • 33. DeCaestecker MP, Bottomley M, Telfer BA. 1993. Detection of abnormal peripheral blood mononuclear cell cytokine networks in human IgA nephropathy. Kidney Int. 44:1298-308
    • (1993) Kidney Int. , vol.44 , pp. 1298-1308
    • DeCaestecker, M.P.1    Bottomley, M.2    Telfer, B.A.3
  • 36
    • 0026843805 scopus 로고
    • Immunopathological aspects of immunoglobulin A nephropathy and other mesangial proliferative glomerulonephritides
    • 34. Schena FP, Gesualdo L, Montinaro V. 1992. Immunopathological aspects of immunoglobulin A nephropathy and other mesangial proliferative glomerulonephritides. J. Am. Soc. Nephrol. 2:167-82
    • (1992) J. Am. Soc. Nephrol. , vol.2 , pp. 167-182
    • Schena, F.P.1    Gesualdo, L.2    Montinaro, V.3
  • 37
    • 0026075060 scopus 로고
    • Omega-3 polyunsaturated fatty acids: A potential new treatment of immune renal disease
    • 35. Donadio JVJ. 1991. Omega-3 polyunsaturated fatty acids: a potential new treatment of immune renal disease. Mayo Clin. Proc. 66:1018
    • (1991) Mayo Clin. Proc. , vol.66 , pp. 1018
    • Donadio, J.V.J.1
  • 38
    • 0023007775 scopus 로고
    • Steroid therapy in IgA nephropathy: A prospective pilot study in moderate proteinuric cases
    • 36. Kobayashi Y, Fujii K, Hiki Y, et al. 1986. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases. Q. J. Med. 61:935-43
    • (1986) Q. J. Med. , vol.61 , pp. 935-943
    • Kobayashi, Y.1    Fujii, K.2    Hiki, Y.3
  • 39
    • 0024600878 scopus 로고
    • Treatment of IgA nephropathy with eicosapentanoic acid (EPA): A two-year prospective trial
    • 37. Bennett WM, Walker RG, Kincaid-Smith PS. 1989. Treatment of IgA nephropathy with eicosapentanoic acid (EPA): a two-year prospective trial. Clin. Nephrol. 31: 128-31
    • (1989) Clin. Nephrol. , vol.31 , pp. 128-131
    • Bennett, W.M.1    Walker, R.G.2    Kincaid-Smith, P.S.3
  • 40
    • 0023942871 scopus 로고
    • A short-term controlled trial of cyclosporine-A in IgA nephropathy
    • 38. Lai KN, Lai M, Vallance-Own J. 1988. A short-term controlled trial of cyclosporine-A in IgA nephropathy. Transplant Proc. 20:297-303
    • (1988) Transplant Proc. , vol.20 , pp. 297-303
    • Lai, K.N.1    Lai, M.2    Vallance-Own, J.3
  • 41
    • 0028107002 scopus 로고
    • Intravenous cyclophosphamide treatment of severe lupus nephritis: A prospective five year study
    • 39. Valeri A, Radhakrishnan J, Estes D, et al. 1994. Intravenous cyclophosphamide treatment of severe lupus nephritis: a prospective five year study. Clin. Nephrol. 42:71-78
    • (1994) Clin. Nephrol. , vol.42 , pp. 71-78
    • Valeri, A.1    Radhakrishnan, J.2    Estes, D.3
  • 42
    • 0026767866 scopus 로고
    • Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis
    • 40. Boumpas DT, Austin HAI, Vaughn EM, et al. 1992. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741-45
    • (1992) Lancet , vol.340 , pp. 741-745
    • Boumpas, D.T.1    Austin, H.A.I.2    Vaughn, E.M.3
  • 43
    • 0030268581 scopus 로고    scopus 로고
    • Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial
    • 41. Gourley MF, Austin HA III, Scott D, et al. 1997. Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial. Ann. Intern. Med. 125:549-57
    • (1997) Ann. Intern. Med. , vol.125 , pp. 549-557
    • Gourley, M.F.1    Austin H.A. III2    Scott, D.3
  • 44
    • 0030940420 scopus 로고    scopus 로고
    • Treatment of lupus nephritis: A meta-analyses of clincal trials
    • 42. Bansal VK, Beto JA. 1997. Treatment of lupus nephritis: a meta-analyses of clincal trials. Am. J. Kidney Dis. 29:193-99
    • (1997) Am. J. Kidney Dis. , vol.29 , pp. 193-199
    • Bansal, V.K.1    Beto, J.A.2
  • 45
    • 0020516034 scopus 로고
    • Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn of cyclosporin A treated (NZB X NZW) F1 mice
    • 43. Israel-Biet D, Noel LH, Bach MA, et al. 1983. Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) of cyclosporin A treated (NZB X NZW) F1 mice. Clin. Exp. Immunol. 54:359
    • (1983) Clin. Exp. Immunol. , vol.54 , pp. 359
    • Israel-Biet, D.1    Noel, L.H.2    Bach, M.A.3
  • 46
    • 0021013001 scopus 로고
    • Response of murine autoimmune disease to cyclosporine and thiols
    • 44. Jones MG, Harris G, Cowing G. 1983. Response of murine autoimmune disease to cyclosporine and thiols. Transplant Proc. 15:2904 (Suppl. 1)
    • (1983) Transplant Proc. , vol.15 , Issue.SUPPL. 1 , pp. 2904
    • Jones, M.G.1    Harris, G.2    Cowing, G.3
  • 47
    • 0021990201 scopus 로고
    • Prolongation of life in female (NZB/NZW)F1 hybrid mice by cyclosporin-A
    • 45. Jones MG, Harris G. 1985. Prolongation of life in female (NZB/NZW)F1 hybrid mice by cyclosporin-A. Clin. Exp. Immunol. 59:1-9
    • (1985) Clin. Exp. Immunol. , vol.59 , pp. 1-9
    • Jones, M.G.1    Harris, G.2
  • 48
    • 0022577930 scopus 로고
    • Successful treatment of autoimmunity in (NZBxNZWF1 mice with cyclosporin and (Nva2)-cyclosporin. I. Reduction of autoantibodies
    • 46. Gunn HC. 1986. Successful treatment of autoimmunity in (NZBxNZW)F1 mice with cyclosporin and (Nva2)-cyclosporin. I. Reduction of autoantibodies. Clin. Exp. Immunol. 64:225-33
    • (1986) Clin. Exp. Immunol. , vol.64 , pp. 225-233
    • Gunn, H.C.1
  • 49
    • 0024377253 scopus 로고
    • Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: Effect of immunosuppressive drugs on disease development
    • 47. Appleby P, Webber DG, Bowen JG. 1989. Murine chronic graft-versus-host disease as a model of systemic lupus erythematosus: effect of immunosuppressive drugs on disease development. Clin. Exp. Immunol. 78:449-53
    • (1989) Clin. Exp. Immunol. , vol.78 , pp. 449-453
    • Appleby, P.1    Webber, D.G.2    Bowen, J.G.3
  • 50
    • 0023893784 scopus 로고
    • The place of cyclosporine A in the treatment of connective tissue diseases
    • 48. Miescher PA, Favre H, Mihatsch MJ, et al. 1994. The place of cyclosporine A in the treatment of connective tissue diseases. Transplant Proc. 20:224-37 (Suppl. 4)
    • (1994) Transplant Proc. , vol.20 , Issue.SUPPL. 4 , pp. 224-237
    • Miescher, P.A.1    Favre, H.2    Mihatsch, M.J.3
  • 51
    • 0002171117 scopus 로고
    • Combined cyclosporine-steroid treatment of systemic-lupus erythematosus
    • ed. R Schindler, Berlin: Springer-Verlag
    • 49. Miescher PA, Miescher A. 1985. Combined cyclosporine-steroid treatment of systemic-lupus erythematosus. In Cyclosporin in Autoimmune Disease, ed. R Schindler, pp. 337-45. Berlin: Springer-Verlag
    • (1985) Cyclosporin in Autoimmune Disease , pp. 337-345
    • Miescher, P.A.1    Miescher, A.2
  • 52
    • 0024571453 scopus 로고
    • Ciclosporin in the treatment of lupus nephritis
    • 50. Favre H, Miescher A, Huang YP, et al. 1989. Ciclosporin in the treatment of lupus nephritis. Am. J. Nephrol. 9:57-60 (Suppl.)
    • (1989) Am. J. Nephrol. , vol.9 , Issue.SUPPL. , pp. 57-60
    • Favre, H.1    Miescher, A.2    Huang, Y.P.3
  • 53
    • 0023606682 scopus 로고
    • Effects of cyclosporine in severe systemic lupus erythematosus
    • 51. Feutren G, Querin S, Noel LH, et al. 1987. Effects of cyclosporine in severe systemic lupus erythematosus. J. Pediatr. 111: 1063-68
    • (1987) J. Pediatr. , vol.111 , pp. 1063-1068
    • Feutren, G.1    Querin, S.2    Noel, L.H.3
  • 54
    • 0028269624 scopus 로고
    • Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity
    • 52. Tokuda M, Kurata N, Mizoguchi A, et al. 1994. Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity. Arthritis Rheum. 37:551-58
    • (1994) Arthritis Rheum. , vol.37 , pp. 551-558
    • Tokuda, M.1    Kurata, N.2    Mizoguchi, A.3
  • 55
    • 0026085306 scopus 로고
    • Can ciclosporin be used without steroids in systemic lupus erythematosus?
    • 53. Enriquez R, Tovar JV, Amoros F, et al. 1991. Can ciclosporin be used without steroids in systemic lupus erythematosus? Nephron 57:367-68
    • (1991) Nephron , vol.57 , pp. 367-368
    • Enriquez, R.1    Tovar, J.V.2    Amoros, F.3
  • 56
    • 0027255407 scopus 로고
    • Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy
    • 54. Hussein MM, Mooij JM, Roujouleh H. 1993. Cyclosporine in the treatment of lupus nephritis including two patients treated during pregnancy. Clin. Nephrol. 40:160-63
    • (1993) Clin. Nephrol. , vol.40 , pp. 160-163
    • Hussein, M.M.1    Mooij, J.M.2    Roujouleh, H.3
  • 57
    • 0013597227 scopus 로고
    • Treatment of systemic lupus with cyclosporin A: A patient with a 1-year follow-up
    • 55. LeFrancois N, Deteix P, Laville M, Zech P. 1984. Treatment of systemic lupus with cyclosporin A: a patient with a 1-year follow-up. Kidney Int. 26:225
    • (1984) Kidney Int. , vol.26 , pp. 225
    • LeFrancois, N.1    Deteix, P.2    Laville, M.3    Zech, P.4
  • 58
    • 0028603461 scopus 로고
    • Use of cyclosporine in the treatment of autoimmune disorders
    • 56. Favre H, Miescher PA, Lemoine R. 1994. Use of cyclosporine in the treatment of autoimmune disorders. Transplant Proc. 26:3194-96
    • (1994) Transplant Proc. , vol.26 , pp. 3194-3196
    • Favre, H.1    Miescher, P.A.2    Lemoine, R.3
  • 59
    • 0000271661 scopus 로고
    • Lupus membranous nephropathy(LMN): Course and prognosis in 50 patients
    • Abstr.
    • 57. Radhakrishnan J, Szabolcs M, D'Agati V, et al. 1993. Lupus membranous nephropathy(LMN): course and prognosis in 50 patients. J. Am. Soc. Nephrol. 4:284 (Abstr.)
    • (1993) J. Am. Soc. Nephrol. , vol.4 , pp. 284
    • Radhakrishnan, J.1    Szabolcs, M.2    D'Agati, V.3
  • 60
    • 0017350006 scopus 로고
    • Lupus nephritis: Clinical course as related to morphologic forms and their transitions
    • Abstr.
    • 58. Baldwin DS, Gluck MC, Lowenstein J, Gallo GR. 1977. Lupus nephritis: clinical course as related to morphologic forms and their transitions. Am. J. Med. 62: 12-30 (Abstr.)
    • (1977) Am. J. Med. , vol.62 , pp. 12-30
    • Baldwin, D.S.1    Gluck, M.C.2    Lowenstein, J.3    Gallo, G.R.4
  • 61
    • 0023614267 scopus 로고
    • Long-term follow-up of patients with lupus nephritis
    • 59. Appel GB, Cohen DJ, Pirani CL, et al. 1987. Long-term follow-up of patients with lupus nephritis. Am. J. Med. 83: 877-85
    • (1987) Am. J. Med. , vol.83 , pp. 877-885
    • Appel, G.B.1    Cohen, D.J.2    Pirani, C.L.3
  • 62
    • 0027068080 scopus 로고
    • Treatment of membranous nephropathy in systemic lupus erythematosus
    • 60. Donadio JVJ. 1992. Treatment of membranous nephropathy in systemic lupus erythematosus. Nephrol. Dial. Transplant. 7:97-104 (Suppl. 1)
    • (1992) Nephrol. Dial. Transplant. , vol.7 , Issue.SUPPL. 1 , pp. 97-104
    • Donadio, J.V.J.1
  • 63
    • 0017888270 scopus 로고
    • Renal involvement in systemic lupus erythematosus (SLE): A study of 56 patients emphasizing histologie classification
    • 61. Appel GB, Silva FG, Pirani CL, et al. 1978. Renal involvement in systemic lupus erythematosus (SLE): a study of 56 patients emphasizing histologie classification. Medicine 57(5):371-410
    • (1978) Medicine , vol.57 , Issue.5 , pp. 371-410
    • Appel, G.B.1    Silva, F.G.2    Pirani, C.L.3
  • 64
    • 0023910907 scopus 로고
    • Cyclosporine in nephrotic syndrome
    • 62. Ponticelli C, Rivolta E. 1988. Cyclosporine in nephrotic syndrome. Transplant Proc. 20:253-58
    • (1988) Transplant Proc. , vol.20 , pp. 253-258
    • Ponticelli, C.1    Rivolta, E.2
  • 65
    • 0026509147 scopus 로고
    • A controlled trial of plasmapheresis therapy in severe lupus nephritis
    • The Lupus Nephritis Collaborative Study Group
    • 63. Lewis EJ, Hunsicker LG, Lan SP, et al. 1992. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N. Engl. J. Med. 326:425-27
    • (1992) N. Engl. J. Med. , vol.326 , pp. 425-427
    • Lewis, E.J.1    Hunsicker, L.G.2    Lan, S.P.3
  • 67
    • 0025664029 scopus 로고
    • Ciclosporin in the treatment of Wegener's granulomatosis (WG) and related diseases
    • 65. Schollmeyer P, Grotz W. 1990. Ciclosporin in the treatment of Wegener's granulomatosis (WG) and related diseases. APMIS Suppl. 19:54-55
    • (1990) APMIS Suppl. , vol.19 , pp. 54-55
    • Schollmeyer, P.1    Grotz, W.2
  • 68
    • 0023919602 scopus 로고
    • Wegener's granulomatosis and cyclosporine
    • 66. Borleffs JCC, Derksen RHWM, Hene RJ. 1988. Wegener's granulomatosis and cyclosporine. Transplant Proc. 20:344-45 (Suppl. 20)
    • (1988) Transplant Proc. , vol.20 , Issue.SUPPL. 20 , pp. 344-345
    • Borleffs, J.C.C.1    Derksen, R.2    Hene, R.J.3
  • 69
    • 0025109601 scopus 로고
    • Wegener's granulomatosis-use of cyclosporin-A: A case report
    • 67. Harley N. Ihle B. 1990. Wegener's granulomatosis-use of cyclosporin-A: a case report. Aust. NZJ. Med. 20:71-73
    • (1990) Aust. NZJ. Med. , vol.20 , pp. 71-73
    • Harley, N.1    Ihle, B.2
  • 70
    • 4243439488 scopus 로고    scopus 로고
    • Cyclosporine for the prevention of relapses in ANCA-associated vasculitis
    • Abstr.
    • 67a. Haubitz M, Koch KM, Brunkhorst R. 1997. Cyclosporine for the prevention of relapses in ANCA-associated vasculitis. J. Am. Soc. Nephrol 8:86A (Abstr.)
    • (1997) J. Am. Soc. Nephrol , vol.8
    • Haubitz, M.1    Koch, K.M.2    Brunkhorst, R.3
  • 72
    • 0026694617 scopus 로고
    • For the international kidney biopsy registry of cyclosporine in autoimmune disease. Risk factors for cyclosporine nephropathy in patients with autoimmune diseases
    • 69. Feutren G, Mihatsch MJ. 1992. For the International Kidney Biopsy Registry of Cyclosporine in Autoimmune Disease. Risk factors for cyclosporine nephropathy in patients with autoimmune diseases. N. Engl. J. Med. 326:1654-60
    • (1992) N. Engl. J. Med. , vol.326 , pp. 1654-1660
    • Feutren, G.1    Mihatsch, M.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.